A team of researchers at the University of Minnesota College of Veterinary Medicine (CVM) led by Molly McCue, DVM, MS, PhD, DACVIM, associate dean for research and professor in the Department of Veterinary Population Medicine at the CVM, recently received nearly $60,000 from the Morris Animal Foundation to investigate the genetic risks for equine pituitary pars intermedia dysfunction (PPID).
In the United States, approximately 12,000 patients present with glioblastoma, a very aggressive brain or spinal cord cancer, each year.
As another touchpoint in a lasting relationship between the University of Minnesota College of Veterinary Medicine (CVM) and the Grand Portage Band of Lake Superior Ojibwe, a team of CVM researchers led by Tiffany Wolf, DVM, PhD, recently received more than $70,000 from project led by Seth Moore, PhD, director of biology and environment at the Grand Portage Band, to continue assisting the tribal nation in investigating moose habitat and population health in a changing climate.
A live recombinant Pichinde virus (PICV) vector vaccine is safe and effective against turkey arthritis reovirus (TARV), according to a recent study led by Sunil Mor, BVSc & AH, MVSc, PhD, and Hinh Ly, PhD. Vaccination may be an effective way to reduce lameness induced by TARV in flocks, but there are currently no commercial TARV vaccines available.
Mild gastrointestinal erosions are more common in dogs treated with anti-inflammatory medications (NSAIDs) over a long period of time than in control dogs with chronic gastrointestinal (GI) disease, according to a recent study led by Tracy Hill, DVM, DACVIM, PhD, DECVIM.